4D Molecular Therapeutics is a biotechnology company.The Company designs, develops, and commercializes transformative gene therapeutic products for unmet medical conditions.

4D Molecular Therapeutics' core mission is centered around revolutionizing the field of gene therapy by developing targeted and optimized adeno-associated virus (AAV) vectors for various genetic diseases. Their primary objective is to create transformative, life-altering treatments for patients suffering from severe genetic disorders, with a focus on precision and efficacy. By leveraging their cutting-edge Therapeutic Vector Evolution platform, 4D Molecular Therapeutics aims to advance the boundaries of gene therapy and improve the quality of life for countless individuals affected by these debilitating conditions.

• Innovation: 4D Molecular Therapeutics values innovation and encourages its employees to think outside the box and explore new ideas to advance the field of gene therapy.
• Collaboration: Collaboration is key to 4D Molecular Therapeutics's success, with a focus on teamwork and open communication to achieve common goals.
• Patient focus: 4D Molecular Therapeutics is dedicated to improving the lives of patients through its innovative gene therapy solutions, putting the needs of patients at the forefront of its mission.
• Diversity and inclusion: 4D Molecular Therapeutics values diversity and inclusivity, fostering a culture that embraces different perspectives and backgrounds to drive innovation and success.